Zobrazeno 1 - 10
of 144
pro vyhledávání: '"Hungta Chen"'
Autor:
Carlos Escobar, Beatriz Palacios, Victoria Gonzalez, Martín Gutiérrez, Mai Duong, Hungta Chen, Nahila Justo, Javier Cid-Ruzafa, Ignacio Hernández, Phillip R. Hunt, Juan F. Delgado
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-14 (2023)
Abstract Objective To describe healthcare resource utilization (HCRU) and costs, in patients with newly diagnosed heart failure (HF) according to ejection fraction (EF) in Spain. Methods Retrospective cohort study that analyzed anonymized, integrated
Externí odkaz:
https://doaj.org/article/5cd285150950429da68a3821325ea69b
Autor:
Carlos Escobar, Beatriz Palacios, Luis Varela, Martín Gutiérrez, Mai Duong, Hungta Chen, Nahila Justo, Javier Cid-Ruzafa, Ignacio Hernández, Phillip R. Hunt, Juan F. Delgado
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-16 (2022)
Abstract Aims To describe healthcare resource utilization (HCRU) of patients with heart failure with preserved (HFpEF), mildly reduced (HFmrEF), and reduced ejection fraction (HFrEF) in Spain. Methods Adults with ≥ 1 HF diagnosis and ≥ 1 year of
Externí odkaz:
https://doaj.org/article/1e346887883241cca4bd4817e2403de7
Autor:
Ali O. Malik, Hungta Chen, Fengming Tang, Paul S. Chan, Andrew Cooper, Marίlia B. Gomes, Vittal Hejjaji, Linong Ji, Kamlesh Khunti, Mikhail Kosiborod, Antonio Nicolucci, Poghni A. Peri-Okonny, Marina V. Shestakova, Jiten Vora, Hirotaka Watada, Suzanne V. Arnold
Publikováno v:
Indian Heart Journal, Vol 74, Iss 5, Pp 398-405 (2022)
Background: We sought to describe global patterns in achievement of risk factor control for primary prevention in patients with T2D and explore the association of country's GNI/capita with risk factor control. Methods: The DISCOVER study is a prospec
Externí odkaz:
https://doaj.org/article/0b861168d8c047968765dcefd3c338f7
Autor:
Markus P Schneider, Navdeep Tangri, Eric Wittbrodt, Toshiki Moriyama, Hungta Chen, Matthew Arnold, Jean Blaise Virgitti, Luca De Nicola, Salvatore Barone, Emily Peach, Krister Järbrink, Pamela Kushner
Publikováno v:
BMJ Open, Vol 13, Iss 5 (2023)
Objectives REVEAL-CKD aims to estimate the prevalence of, and factors associated with, undiagnosed stage 3 chronic kidney disease (CKD).Design Multinational, observational study.Setting Data from six country-specific electronic medical records and/or
Externí odkaz:
https://doaj.org/article/7ec4f132de374173bd6a55d92c633e4f
Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER
Autor:
Suzanne V. Arnold, Fengming Tang, Andrew Cooper, Hungta Chen, Marilia B. Gomes, Wolfgang Rathmann, Iichiro Shimomura, Jiten Vora, Hirotaka Watada, Kamlesh Khunti, Mikhail Kosiborod
Publikováno v:
BMC Endocrine Disorders, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background Despite strong evidence of benefit, uptake of newer glucose-lowering medications that reduce cardiovascular risk has been low. We sought to examine global trends and predictors of use of SGLT2i and GLP-1 RA in patients with type 2
Externí odkaz:
https://doaj.org/article/ec3b44102c7e4396b62acc311ae65d72
Autor:
Kamlesh Khunti, Mikhail Kosiborod, Dae Jung Kim, Shun Kohsaka, Carolyn S. P. Lam, Su-Yen Goh, Chern-En Chiang, Jonathan E. Shaw, Matthew A. Cavender, Navdeep Tangri, Josep Franch-Nadal, Reinhard W. Holl, Marit E. Jørgensen, Anna Norhammar, Johan G. Eriksson, Francesco Zaccardi, Avraham Karasik, Dianna J. Magliano, Marcus Thuresson, Hungta Chen, Eric Wittbrodt, Johan Bodegård, Filip Surmont, Peter Fenici, the CVD-REAL Investigators and Study Group
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-15 (2021)
Abstract Background Randomized, controlled cardiovascular outcome trials may not be fully representative of the management of patients with type 2 diabetes across different geographic regions. We conducted analyses of data from the multinational CVD-
Externí odkaz:
https://doaj.org/article/84b501fd6bee4a8d9bef97cb73d7d10c
Autor:
Suzanne V. Arnold, Kamlesh Khunti, Fabrice Bonnet, Bernard Charbonnel, Hungta Chen, Javier Cid‐Ruzafa, Andrew Cooper, Peter Fenici, Marilia B. Gomes, Niklas Hammar, Linong Ji, Gabriela Luporini‐Saraiva, Jesús Medina, Antonio Nicolucci, Larisa Ramirez, Marina V. Shestakova, Iichiro Shimomura, Filip Surmont, Fengming Tang, Jiten Vora, Hirotaka Watada, Mikhail Kosiborod, the DISCOVER investigators
Publikováno v:
ESC Heart Failure, Vol 8, Iss 2, Pp 1711-1716 (2021)
Abstract Aims Heart failure (HF) is increasingly recognized as a major cause of morbidity and mortality in patients with type 2 diabetes (T2D), but the global epidemiology and treatment of HF in T2D are not well defined. This study aimed to examine t
Externí odkaz:
https://doaj.org/article/6f0d5cf6e07a4fcc98c4a0e71fee4e3d
Autor:
Marília B. Gomes, Fengming Tang, Hungta Chen, Javier Cid-Ruzafa, Peter Fenici, Kamlesh Khunti, Wolfgang Rathmann, Marina V. Shestakova, Filip Surmont, Hirotaka Watada, Jesús Medina, Iichiro Shimomura, Gabriela Luporini Saraiva, Andrew Cooper, Antonio Nicolucci
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
DISCOVER is a 3-year observational study program of 15,983 people with type 2 diabetes initiating second-line glucose-lowering therapy in 38 countries. We investigated the association between socioeconomic status and both the availability of a baseli
Externí odkaz:
https://doaj.org/article/6c2277abaa80486181f4c6426ca2717c
Autor:
Suzanne V. Arnold, Kamlesh Khunti, Fengming Tang, Hungta Chen, Antonio Nicolucci, Marilia B. Gomes, Linong Ji, Marina V. Shestakova, Hirotaka Watada, Andrew Cooper, Peter Fenici, Niklas Hammar, Jesús Medina, Mikhail Kosiborod, the DISCOVER investigators
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 5, Iss 2, Pp n/a-n/a (2022)
Abstract Background The key goals of management in patients with type 2 diabetes (T2D) are to prolong life and improve quality of life. Micro‐ and macrovascular complications of T2D not only increase the risk of morbidity and mortality, but cross
Externí odkaz:
https://doaj.org/article/9ed190f5132449e2ae21f646b8e71319
Autor:
Jesús Medina, Peter Fenici, Fengming Tang, Hirotaka Watada, Antonio Nicolucci, Iichiro Shimomura, Mikhail Kosiborod, Hungta Chen, Andrew Cooper, Brenda Bongaerts, Bernard H Charbonnel, Marilia Gomes, Marina Shestakova
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 9, Iss 1 (2021)
Introduction Although individualized target glycated hemoglobin (HbA1c) levels are recommended in older people with type 2 diabetes, studies report high levels of potential overtreatment. We aimed to investigate the proportion of older patients (aged
Externí odkaz:
https://doaj.org/article/43da6cdaaf924397ad77881be216d19f